Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Hughes DM, Toste C, Nelson C, Escalon J, Blevins F, Shah B. Transitioning From Thrombopoietin Agonists to the Novel SYK Inhibitor Fostamatinib: A Multicenter, Real-World Case Series. J Adv Pract Oncol. 2021 Jul; 12(5):508-517. PMID: 34430061; PMCID: PMC8299792; DOI: 10.6004/jadpro.2021.12.5.6;
Milrod CJ, Blevins F, Hughes D, Lerner A, Sarosiek S, Sanchorawala V, Sloan JM. Incidence of skin hyperpigmentation in Black patients receiving treatment with immunomodulatory drugs. Blood. 2021 May 27; 137(21):2987-2989.View Related Profiles. PMID: 33728443
David Hughes, PharmD, Frances Blevins, PA-C, Bhavesh Shah, RPh, Shayna Sarosiek, Adam Lerner, MD, John Mark Sloan, MD. Blood. Real-World Experience with Fostamatinib in Patients with Immune Thrombocytopenia at an Academic Medical Center. ASH Publications. 2019. View Publication
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.